Sarepta Therapeutics (SRPT) Current Taxes (2017 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Current Taxes of $13.8 million for Q1 2026, down 82.73% year-over-year from $79.9 million in Q1 2025, and up 189.99% quarter-over-quarter from $4.8 million in Q4 2025.
Sarepta Therapeutics (SRPT) Current Taxes (2017 - 2026) Analysis & Trends
Sarepta Therapeutics' Current Taxes history runs 8 years deep, the most recent figure standing at $13.8 million for Q1 2026.
- In Q1 2026, Current Taxes fell 82.73% year-over-year to $13.8 million; the TTM figure through Mar 2026 stood at $13.8 million (down 82.73% YoY), while the FY2025 annual figure was $4.8 million, down 72.66% from the prior year.
- Current Taxes for Q1 2026 stood at $13.8 million, up from $4.8 million in the prior quarter.
- The five-year high for Current Taxes was $79.9 million in Q1 2025, with the low at $4.1 million in Q3 2022.
- The 5-year median for Current Taxes is $16.1 million (2023), against an average of $19.5 million.
- The sharpest annual moves came in 2022 and 2026: Current Taxes surged 5696.76% in 2022, then tumbled 82.73% in 2026.
- Sarepta Therapeutics' Current Taxes stood at $12.5 million in 2022, then climbed by 9.94% to $13.8 million in 2023, then gained by 26.33% to $17.4 million in 2024, then tumbled by 72.66% to $4.8 million in 2025, then jumped by 189.99% to $13.8 million in 2026.
- Business Quant data shows SRPT's Current Taxes at $13.8 million in Q1 2026, $4.8 million in Q4 2025, and $9.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.31 Mn |
| Mar 31, 2026 | 13.79 Mn |
| Dec 31, 2025 | 4.76 Mn |
| Sep 30, 2025 | 9.09 Mn |
| Jun 30, 2025 | 18.73 Mn |
| Mar 31, 2025 | 79.86 Mn |
| Dec 31, 2024 | 17.39 Mn |
| Mar 31, 2024 | 18.29 Mn |
| Dec 31, 2023 | 13.77 Mn |
| Sep 30, 2023 | 24.68 Mn |
| Jun 30, 2023 | 20.82 Mn |
| Mar 31, 2023 | 16.09 Mn |
| Dec 31, 2022 | 12.52 Mn |
| Sep 30, 2022 | 4.10 Mn |
| Dec 31, 2021 | 216,000.00 |
| Dec 31, 2018 | 301,000.00 |
| Jun 30, 2018 | 523,000.00 |
| Mar 31, 2018 | 943,000.00 |
| Dec 31, 2017 | 943,000.00 |
| Sep 30, 2017 | 3.49 Mn |